U.S. markets close in 1 hour 1 minute

Xiaobai Maimai Inc. (HX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
6.10-3.04 (-33.23%)
As of 2:59PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close9.14
Bid5.95 x 1000
Ask5.98 x 1800
Day's Range5.15 - 8.99
52 Week Range1.23 - 22.39
Avg. Volume2,109,053
Market Cap99.37M
Beta (5Y Monthly)1.00
PE Ratio (TTM)N/A
EPS (TTM)-2.14
Earnings DateDec 21, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateAug 01, 2018
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for HX

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Xiaobai Maimai Inc.
    Analyst Report: American Express CompanyAmerican Express is a global financial institution, operating in about 130 countries, that provides consumers and businesses charge and credit card payment products. The company also operates a highly profitable merchant payment network. Since 2018, the company has operated in three segments: global consumer services, global commercial services, and global merchant and network services. In addition to payment products, the company's commercial business offers expense management tools, consulting services, and business loans.
    Fair Value
    Economic Moat
    3 months agoMorningstar
View more
  • PR Newswire

    Xiaobai Maimai Appoints Dr. Yingxian Liu as Medical Consultant for We Health Limited

    Xiaobai Maimai Inc. (NASDAQ: HX) ("Xiaobai Maimai," the "Company," or "we"), today announced the appointment of Dr. Yingxian Liu as the medical consultant to the Company. Dr. Liu will work closely with management to develop the Company's cancer therapy and radiation oncology business by the Company's wholly-owned subsidiary, We Health Limited.

  • PR Newswire

    Xiaobai Maimai Plans to Enter the U.S. Radiation Oncology Services Market

    Xiaobai Maimai Inc. (NASDAQ: HX) ("Xiaobai Maimai", the "Company", or "we"), a social e-commerce platform in China, today announced that it plans to enter the radiation oncology services market in the U.S.

  • PR Newswire

    Xiaobai Maimai Files Annual Report on Form 20-F for Fiscal Year 2021

    Xiaobai Maimai Inc. (NASDAQ: HX), formerly known as Hexindai Inc. ("Xiaobai Maimai", the "Company", or "we"), a social e-commerce platform in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended March 31, 2021 with the U.S. Securities and Exchange Commission ("SEC") on July 28, 2021. The annual report on Form 20-F, which contains its audited financial statements, can be accessed on the SEC's website at as well as via the Company's inves